Physician

Amanur Mohammed Rahman, M.D.

According to 2025 Medicare claims, Amanur Rahman, M.D. (NPI: 1104162502) practices general practice in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bronx, NY. This provider's primary affiliated billing organization is ESSEN MEDICAL ASSOCIATES, PC (NPI: 1366418709; TIN: 582501863) and primary practice location at 10459-4308. Rahman is affiliated with the SOMOS ACO (ACO ID: A4577) and ATLAS IPA, LLC (ACO ID: D0095), participating under both the MSSP and REACH models.

Rahman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 178 traditional Medicare patients, billed 241 HCPCS/CPT codes, and received $14,632 in Medicare payments. The top billing code was 99442 (Telephone medical discussion with physician, 11-20 minutes). Part D data shows 1,889 prescription claims across 564 beneficiaries totaling $209,963 in drug costs, led by Triumeq (Abacavir/Dolutegravir/Lamivudi). DME data shows 66 claims. Open Payments data shows 1 records totaling $22. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $179,737 to $14,632. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $509 and ending at $209,963. For DME billing, reported payments fell sharply in recent years, from $8,196 to $31,733.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	138	2,358	$179,737
2017	394	3,780	$298,468
2018	277	1,698	$145,921
2019	50	108	$5,836
2020	240	291	$19,802
2021	219	509	$18,468
2022	94	240	$10,707
2023	69	147	$7,684
2024	178	241	$14,632

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	13	21	$509
2016	189	4,719	$284,937
2017	536	13,944	$981,994
2018	374	8,362	$544,945
2019	334	2,244	$116,155
2020	190	685	$28,311
2021	131	360	$16,595
2022	172	446	$29,783
2023	266	813	$96,826
2024	564	1,889	$209,963

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	287	$23,969
2017	N/R	558	$54,855
2018	138	762	$25,927
2019	29	185	$5,517
2020	N/R	14	$3,445
2021	N/R	12	$53
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	66	66	$31,465

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99442	Telephone medical discussion with physician, 11-20 minutes	85	87	$79
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	39	47	$70
99441	Telephone medical discussion with physician, 5-10 minutes	40	40	$47
87426	Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus	11	15	$35

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Triumeq	Abacavir/Dolutegravir/Lamivudi	11	330	$40,789
Trulicity	Dulaglutide	16	534	$17,879
Jardiance	Empagliflozin	16	870	$16,748
Eliquis	Apixaban	17	750	$14,589
Januvia	Sitagliptin Phosphate	14	660	$11,746

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	33	33	$23,412
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	33	33	$8,054

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$22	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amanur Mohammed Rahman, M.D.?

Tedicare shows public-source Medicare data for Amanur Mohammed Rahman, M.D. (NPI 1104162502), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amanur Mohammed Rahman, M.D. have ACO affiliation data?

Amanur Mohammed Rahman, M.D. is shown with ACO affiliation data for SOMOS ACO (MSSP, ACO ID A4577) and ATLAS IPA, LLC (REACH, ACO ID D0095).

What billing organization is linked to Amanur Mohammed Rahman, M.D.?

Amanur Mohammed Rahman, M.D. is linked to ESSEN MEDICAL ASSOCIATES, PC (billing NPI 1366418709) in the available physician profile data.

Does Amanur Mohammed Rahman, M.D. have Open Payments data?

Amanur Mohammed Rahman, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.